<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>SatyaBio ‚Äî Biotech Competitive Intelligence</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Mono:wght@400;500;600&family=Instrument+Serif:ital@0;1&family=Outfit:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --bg-primary: #0a0a0b;
            --bg-secondary: #111113;
            --bg-tertiary: #18181b;
            --bg-card: #1a1a1d;
            --text-primary: #fafafa;
            --text-secondary: #a1a1aa;
            --text-muted: #71717a;
            --accent-primary: #22c55e;
            --accent-secondary: #4ade80;
            --accent-glow: rgba(34, 197, 94, 0.12);
            --accent-blue: #3b82f6;
            --accent-purple: #a855f7;
            --accent-red: #ef4444;
            --accent-yellow: #eab308;
            --accent-orange: #f97316;
            --border-color: rgba(255, 255, 255, 0.08);
            --border-hover: rgba(255, 255, 255, 0.15);
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }
        html { scroll-behavior: smooth; }

        body {
            font-family: 'Outfit', -apple-system, sans-serif;
            background: var(--bg-primary);
            color: var(--text-primary);
            line-height: 1.6;
            overflow-x: hidden;
        }

        body::before {
            content: '';
            position: fixed;
            top: 0; left: 0; width: 100%; height: 100%;
            background-image: url("data:image/svg+xml,%3Csvg viewBox='0 0 256 256' xmlns='http://www.w3.org/2000/svg'%3E%3Cfilter id='n'%3E%3CfeTurbulence type='fractalNoise' baseFrequency='0.9' numOctaves='4' stitchTiles='stitch'/%3E%3C/filter%3E%3Crect width='100%25' height='100%25' filter='url(%23n)'/%3E%3C/svg%3E");
            opacity: 0.03;
            pointer-events: none;
            z-index: 1000;
        }

        /* Navigation */
        nav {
            position: fixed;
            top: 0; left: 0; right: 0;
            z-index: 100;
            padding: 1rem 2rem;
            background: rgba(10, 10, 11, 0.85);
            backdrop-filter: blur(20px);
            border-bottom: 1px solid var(--border-color);
        }

        .nav-container {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .logo {
            display: flex;
            align-items: center;
            gap: 0.6rem;
            text-decoration: none;
        }

        .logo-icon {
            width: 32px; height: 32px;
            background: linear-gradient(135deg, var(--accent-primary), var(--accent-blue));
            border-radius: 6px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-family: 'IBM Plex Mono', monospace;
            font-weight: 600;
            font-size: 1rem;
            color: var(--bg-primary);
        }

        .logo-text {
            font-weight: 600;
            font-size: 1.15rem;
            color: var(--text-primary);
        }

        .nav-links {
            display: flex;
            align-items: center;
            gap: 2rem;
        }

        .nav-links a {
            color: var(--text-secondary);
            text-decoration: none;
            font-size: 0.875rem;
            transition: color 0.2s;
        }

        .nav-links a:hover { color: var(--text-primary); }

        .btn {
            padding: 0.6rem 1.15rem;
            border-radius: 6px;
            font-size: 0.875rem;
            font-weight: 500;
            text-decoration: none;
            transition: all 0.2s;
            cursor: pointer;
            border: none;
            font-family: inherit;
        }

        .btn-ghost {
            background: transparent;
            color: var(--text-secondary);
        }

        .btn-ghost:hover { color: var(--text-primary); }

        .btn-primary {
            background: var(--text-primary);
            color: var(--bg-primary);
        }

        .btn-primary:hover { background: #e4e4e7; }

        .btn-accent {
            background: var(--accent-primary);
            color: var(--bg-primary);
            font-weight: 600;
        }

        .btn-accent:hover {
            background: var(--accent-secondary);
            box-shadow: 0 8px 30px var(--accent-glow);
        }

        .btn-large {
            padding: 0.9rem 1.75rem;
            font-size: 0.95rem;
        }

        /* Hero Section */
        .hero {
            min-height: 100vh;
            padding: 9rem 2rem 5rem;
            display: flex;
            flex-direction: column;
            justify-content: center;
        }

        .hero-container {
            max-width: 1400px;
            margin: 0 auto;
            width: 100%;
        }

        .hero-eyebrow {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.75rem;
            color: var(--accent-primary);
            text-transform: uppercase;
            letter-spacing: 0.15em;
            margin-bottom: 1.5rem;
            display: flex;
            align-items: center;
            gap: 0.75rem;
        }

        .hero-eyebrow::before {
            content: '';
            width: 24px;
            height: 1px;
            background: var(--accent-primary);
        }

        .hero-title {
            font-family: 'Instrument Serif', Georgia, serif;
            font-size: clamp(2.75rem, 6vw, 4.5rem);
            font-weight: 400;
            line-height: 1.08;
            letter-spacing: -0.03em;
            margin-bottom: 1.5rem;
            max-width: 900px;
        }

        .hero-title .highlight {
            color: var(--accent-primary);
            font-style: italic;
        }

        .hero-subtitle {
            font-size: 1.2rem;
            color: var(--text-secondary);
            max-width: 680px;
            margin-bottom: 2.5rem;
            line-height: 1.7;
        }

        .hero-cta {
            display: flex;
            gap: 1rem;
            margin-bottom: 4rem;
        }

        /* Question Cards */
        .hero-questions {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.25rem;
            max-width: 1000px;
        }

        .question-card {
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 12px;
            padding: 1.5rem;
            transition: all 0.3s ease;
            cursor: pointer;
        }

        .question-card:hover {
            border-color: var(--accent-primary);
            transform: translateY(-2px);
        }

        .question-icon {
            font-size: 1.5rem;
            margin-bottom: 1rem;
        }

        .question-text {
            font-size: 0.95rem;
            color: var(--text-secondary);
            font-style: italic;
            line-height: 1.5;
        }

        .question-text::before { content: '"'; color: var(--accent-primary); }
        .question-text::after { content: '"'; color: var(--accent-primary); }

        .question-answer {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--text-muted);
            margin-top: 1rem;
            text-transform: uppercase;
            letter-spacing: 0.1em;
        }

        /* Disease Landscape Section */
        .landscape-section {
            padding: 7rem 2rem;
            background: var(--bg-secondary);
            border-top: 1px solid var(--border-color);
        }

        .section-container {
            max-width: 1400px;
            margin: 0 auto;
        }

        .section-header {
            margin-bottom: 3.5rem;
        }

        .section-eyebrow {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--accent-primary);
            text-transform: uppercase;
            letter-spacing: 0.2em;
            margin-bottom: 1rem;
        }

        .section-title {
            font-family: 'Instrument Serif', Georgia, serif;
            font-size: clamp(2rem, 4vw, 3rem);
            font-weight: 400;
            letter-spacing: -0.02em;
            margin-bottom: 1rem;
        }

        .section-subtitle {
            font-size: 1.1rem;
            color: var(--text-secondary);
            max-width: 600px;
        }

        /* Landscape Demo */
        .landscape-demo {
            display: grid;
            grid-template-columns: 300px 1fr;
            gap: 1.5rem;
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 16px;
            overflow: hidden;
        }

        .landscape-sidebar {
            background: var(--bg-tertiary);
            padding: 1.5rem;
            border-right: 1px solid var(--border-color);
        }

        .sidebar-title {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 1rem;
        }

        .indication-list {
            list-style: none;
        }

        .indication-item {
            padding: 0.75rem 1rem;
            border-radius: 8px;
            font-size: 0.9rem;
            color: var(--text-secondary);
            cursor: pointer;
            transition: all 0.2s;
            margin-bottom: 0.25rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .indication-item:hover { background: var(--bg-primary); color: var(--text-primary); }

        .indication-item.active {
            background: var(--accent-primary);
            color: var(--bg-primary);
        }

        .indication-count {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.75rem;
            opacity: 0.7;
        }

        .landscape-main {
            padding: 1.5rem;
        }

        .landscape-header {
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
            margin-bottom: 1.5rem;
            padding-bottom: 1.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .landscape-indication {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 0.35rem;
        }

        .landscape-full-name {
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        .landscape-stats {
            display: flex;
            gap: 2rem;
        }

        .landscape-stat {
            text-align: right;
        }

        .landscape-stat-value {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 1.5rem;
            font-weight: 600;
        }

        .landscape-stat-value.green { color: var(--accent-primary); }
        .landscape-stat-value.blue { color: var(--accent-blue); }
        .landscape-stat-value.orange { color: var(--accent-orange); }

        .landscape-stat-label {
            font-size: 0.7rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* Unmet Need Box */
        .unmet-need {
            background: rgba(239, 68, 68, 0.08);
            border: 1px solid rgba(239, 68, 68, 0.2);
            border-radius: 10px;
            padding: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .unmet-need-title {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--accent-red);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 0.5rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .unmet-need-text {
            font-size: 0.9rem;
            color: var(--text-secondary);
            line-height: 1.6;
        }

        /* SOC Box */
        .soc-box {
            background: var(--bg-primary);
            border: 1px solid var(--border-color);
            border-radius: 10px;
            padding: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .soc-title {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 1rem;
        }

        .soc-drugs {
            display: flex;
            gap: 1rem;
            flex-wrap: wrap;
        }

        .soc-drug {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem 1rem;
            background: var(--bg-tertiary);
            border-radius: 8px;
            flex: 1;
            min-width: 200px;
        }

        .soc-drug-info h4 {
            font-size: 0.9rem;
            font-weight: 600;
            margin-bottom: 0.15rem;
        }

        .soc-drug-info span {
            font-size: 0.75rem;
            color: var(--text-muted);
        }

        .soc-drug-sales {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.85rem;
            color: var(--accent-primary);
            margin-left: auto;
        }

        /* Competitive Pipeline Table */
        .pipeline-section {
            margin-top: 1.5rem;
        }

        .pipeline-title {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 1rem;
        }

        .pipeline-table {
            width: 100%;
            font-size: 0.8rem;
            border-collapse: collapse;
        }

        .pipeline-table th {
            text-align: left;
            padding: 0.75rem;
            background: var(--bg-tertiary);
            color: var(--text-muted);
            font-weight: 500;
            font-size: 0.7rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            font-family: 'IBM Plex Mono', monospace;
        }

        .pipeline-table th:first-child { border-radius: 6px 0 0 6px; }
        .pipeline-table th:last-child { border-radius: 0 6px 6px 0; }

        .pipeline-table td {
            padding: 0.85rem 0.75rem;
            border-bottom: 1px solid var(--border-color);
            color: var(--text-secondary);
        }

        .pipeline-table tr:last-child td { border-bottom: none; }

        .company-cell {
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .company-ticker {
            font-family: 'IBM Plex Mono', monospace;
            font-weight: 600;
            color: var(--accent-blue);
            font-size: 0.8rem;
        }

        .company-name {
            color: var(--text-primary);
            font-weight: 500;
        }

        .drug-name {
            color: var(--text-primary);
            font-weight: 500;
        }

        .phase-badge {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            padding: 0.25rem 0.6rem;
            border-radius: 4px;
            font-weight: 500;
        }

        .phase-3 { background: rgba(34, 197, 94, 0.15); color: var(--accent-primary); }
        .phase-2 { background: rgba(234, 179, 8, 0.15); color: var(--accent-yellow); }
        .phase-1 { background: rgba(168, 85, 247, 0.15); color: var(--accent-purple); }
        .approved { background: rgba(59, 130, 246, 0.15); color: var(--accent-blue); }

        .moa-text {
            font-size: 0.75rem;
            color: var(--text-muted);
        }

        .differentiation {
            font-size: 0.75rem;
            color: var(--text-secondary);
            max-width: 200px;
        }

        /* Clinical Data Section */
        .clinical-section {
            padding: 7rem 2rem;
            background: var(--bg-primary);
            border-top: 1px solid var(--border-color);
        }

        .clinical-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 3rem;
            align-items: start;
        }

        .clinical-content h3 {
            font-family: 'Instrument Serif', Georgia, serif;
            font-size: 2rem;
            font-weight: 400;
            margin-bottom: 1.5rem;
        }

        .clinical-content p {
            color: var(--text-secondary);
            margin-bottom: 1.5rem;
            line-height: 1.7;
        }

        .clinical-features {
            list-style: none;
        }

        .clinical-features li {
            display: flex;
            align-items: flex-start;
            gap: 0.75rem;
            padding: 0.75rem 0;
            font-size: 0.95rem;
            color: var(--text-secondary);
            border-bottom: 1px solid var(--border-color);
        }

        .clinical-features li:last-child { border-bottom: none; }

        .clinical-features li::before {
            content: '‚Üí';
            color: var(--accent-primary);
            font-weight: 600;
        }

        /* Efficacy Comparison Table */
        .efficacy-demo {
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 12px;
            overflow: hidden;
        }

        .efficacy-header {
            padding: 1rem 1.25rem;
            background: var(--bg-tertiary);
            border-bottom: 1px solid var(--border-color);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .efficacy-title {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.75rem;
            color: var(--text-muted);
        }

        .efficacy-indication {
            font-size: 0.8rem;
            color: var(--text-secondary);
        }

        .efficacy-body {
            padding: 1.25rem;
        }

        .efficacy-table {
            width: 100%;
            font-size: 0.8rem;
            border-collapse: collapse;
        }

        .efficacy-table th {
            text-align: left;
            padding: 0.6rem;
            color: var(--text-muted);
            font-weight: 500;
            font-size: 0.7rem;
            text-transform: uppercase;
            font-family: 'IBM Plex Mono', monospace;
            border-bottom: 1px solid var(--border-color);
        }

        .efficacy-table td {
            padding: 0.75rem 0.6rem;
            border-bottom: 1px solid var(--border-color);
        }

        .efficacy-table tr:last-child td { border-bottom: none; }

        .drug-cell {
            font-weight: 500;
            color: var(--text-primary);
        }

        .efficacy-value {
            font-family: 'IBM Plex Mono', monospace;
            font-weight: 600;
        }

        .efficacy-value.high { color: var(--accent-primary); }
        .efficacy-value.medium { color: var(--accent-yellow); }
        .efficacy-value.low { color: var(--text-secondary); }

        .safety-cell {
            display: flex;
            gap: 0.5rem;
        }

        .ae-badge {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.65rem;
            padding: 0.2rem 0.5rem;
            border-radius: 3px;
            background: var(--bg-tertiary);
            color: var(--text-muted);
        }

        .ae-badge.warning {
            background: rgba(239, 68, 68, 0.15);
            color: var(--accent-red);
        }

        /* Features Grid */
        .features-section {
            padding: 7rem 2rem;
            background: var(--bg-secondary);
            border-top: 1px solid var(--border-color);
        }

        .features-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.5rem;
        }

        .feature-card {
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 12px;
            padding: 1.75rem;
            transition: all 0.3s ease;
        }

        .feature-card:hover {
            border-color: var(--border-hover);
            transform: translateY(-3px);
        }

        .feature-icon {
            font-size: 1.75rem;
            margin-bottom: 1.25rem;
        }

        .feature-title {
            font-size: 1.1rem;
            font-weight: 600;
            margin-bottom: 0.6rem;
        }

        .feature-description {
            font-size: 0.9rem;
            color: var(--text-secondary);
            line-height: 1.6;
        }

        /* Workflow Section */
        .workflow-section {
            padding: 7rem 2rem;
            background: var(--bg-primary);
            border-top: 1px solid var(--border-color);
        }

        .workflow-grid {
            display: grid;
            grid-template-columns: repeat(4, 1fr);
            gap: 1.5rem;
            margin-top: 3rem;
        }

        .workflow-step {
            text-align: center;
            position: relative;
        }

        .workflow-step::after {
            content: '‚Üí';
            position: absolute;
            right: -1rem;
            top: 2.5rem;
            color: var(--text-muted);
            font-size: 1.25rem;
        }

        .workflow-step:last-child::after { display: none; }

        .workflow-number {
            width: 56px; height: 56px;
            background: var(--bg-tertiary);
            border: 1px solid var(--border-color);
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 0 auto 1.25rem;
            font-family: 'IBM Plex Mono', monospace;
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--accent-primary);
        }

        .workflow-title {
            font-weight: 600;
            margin-bottom: 0.5rem;
        }

        .workflow-desc {
            font-size: 0.85rem;
            color: var(--text-secondary);
            line-height: 1.5;
        }

        /* Pricing */
        .pricing-section {
            padding: 7rem 2rem;
            background: var(--bg-secondary);
            border-top: 1px solid var(--border-color);
        }

        .pricing-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.5rem;
            max-width: 1000px;
            margin: 3rem auto 0;
        }

        .pricing-card {
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 14px;
            padding: 2rem;
            position: relative;
        }

        .pricing-card.featured {
            border-color: var(--accent-primary);
        }

        .pricing-card.featured::before {
            content: 'Most Popular';
            position: absolute;
            top: -10px;
            left: 50%;
            transform: translateX(-50%);
            padding: 0.3rem 0.9rem;
            background: var(--accent-primary);
            color: var(--bg-primary);
            font-size: 0.65rem;
            font-weight: 600;
            border-radius: 100px;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .pricing-name {
            font-weight: 600;
            font-size: 1.05rem;
            margin-bottom: 0.25rem;
        }

        .pricing-for {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 1.25rem;
        }

        .pricing-price {
            font-family: 'Instrument Serif', Georgia, serif;
            font-size: 2.5rem;
            margin-bottom: 0.15rem;
        }

        .pricing-price span {
            font-family: 'Outfit', sans-serif;
            font-size: 1rem;
            color: var(--text-secondary);
        }

        .pricing-period {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 1.5rem;
        }

        .pricing-features {
            list-style: none;
            margin-bottom: 1.5rem;
        }

        .pricing-features li {
            display: flex;
            align-items: flex-start;
            gap: 0.5rem;
            padding: 0.45rem 0;
            font-size: 0.85rem;
            color: var(--text-secondary);
        }

        .pricing-features li::before {
            content: '‚úì';
            color: var(--accent-primary);
            font-weight: 600;
        }

        .pricing-card .btn {
            width: 100%;
            text-align: center;
        }

        /* CTA */
        .cta-section {
            padding: 7rem 2rem;
            background: var(--bg-primary);
            border-top: 1px solid var(--border-color);
            text-align: center;
            position: relative;
        }

        .cta-section::before {
            content: '';
            position: absolute;
            top: 0;
            left: 50%;
            transform: translateX(-50%);
            width: 500px;
            height: 300px;
            background: radial-gradient(ellipse, var(--accent-glow), transparent 70%);
            pointer-events: none;
        }

        .cta-container {
            max-width: 600px;
            margin: 0 auto;
            position: relative;
            z-index: 1;
        }

        .cta-title {
            font-family: 'Instrument Serif', Georgia, serif;
            font-size: clamp(1.75rem, 3.5vw, 2.5rem);
            font-weight: 400;
            margin-bottom: 1rem;
        }

        .cta-subtitle {
            font-size: 1rem;
            color: var(--text-secondary);
            margin-bottom: 2rem;
        }

        .cta-form {
            display: flex;
            gap: 0.75rem;
            max-width: 420px;
            margin: 0 auto;
        }

        .cta-form input {
            flex: 1;
            padding: 0.85rem 1rem;
            background: var(--bg-tertiary);
            border: 1px solid var(--border-color);
            border-radius: 8px;
            color: var(--text-primary);
            font-family: inherit;
            font-size: 0.9rem;
        }

        .cta-form input:focus {
            outline: none;
            border-color: var(--accent-primary);
        }

        /* Footer */
        footer {
            padding: 2.5rem 2rem;
            background: var(--bg-secondary);
            border-top: 1px solid var(--border-color);
        }

        .footer-container {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .footer-links {
            display: flex;
            gap: 2rem;
        }

        .footer-links a {
            color: var(--text-muted);
            text-decoration: none;
            font-size: 0.85rem;
            transition: color 0.2s;
        }

        .footer-links a:hover { color: var(--text-primary); }

        .footer-copy {
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* News Section */
        .news-section {
            padding: 7rem 2rem;
            background: var(--bg-secondary);
            border-top: 1px solid var(--border-color);
        }

        .news-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.5rem;
        }

        .news-card {
            background: var(--bg-card);
            border: 1px solid var(--border-color);
            border-radius: 12px;
            padding: 1.5rem;
            transition: all 0.3s ease;
        }

        .news-card:hover {
            border-color: var(--border-hover);
            transform: translateY(-3px);
        }

        .news-card.featured {
            border-color: var(--accent-primary);
            background: linear-gradient(180deg, rgba(34, 197, 94, 0.05) 0%, var(--bg-card) 100%);
        }

        .news-tag {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.65rem;
            text-transform: uppercase;
            letter-spacing: 0.1em;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
        }

        .news-ticker {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--accent-primary);
            margin-bottom: 0.5rem;
        }

        .news-title {
            font-size: 1rem;
            font-weight: 600;
            margin-bottom: 0.75rem;
            line-height: 1.4;
        }

        .news-summary {
            font-size: 0.85rem;
            color: var(--text-secondary);
            line-height: 1.6;
            margin-bottom: 1rem;
        }

        .news-meta {
            display: flex;
            flex-direction: column;
            gap: 0.5rem;
        }

        .news-catalyst {
            font-size: 0.75rem;
            color: var(--text-muted);
        }

        .news-sentiment {
            font-family: 'IBM Plex Mono', monospace;
            font-size: 0.7rem;
            padding: 0.25rem 0.6rem;
            border-radius: 4px;
            width: fit-content;
        }

        .news-sentiment.positive {
            background: rgba(34, 197, 94, 0.15);
            color: var(--accent-primary);
        }

        .news-sentiment.negative {
            background: rgba(239, 68, 68, 0.15);
            color: var(--accent-red);
        }

        .news-sentiment.neutral {
            background: rgba(234, 179, 8, 0.15);
            color: var(--accent-yellow);
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .hero-questions { grid-template-columns: 1fr; }
            .landscape-demo { grid-template-columns: 1fr; }
            .landscape-sidebar { border-right: none; border-bottom: 1px solid var(--border-color); }
            .clinical-grid { grid-template-columns: 1fr; }
            .features-grid { grid-template-columns: repeat(2, 1fr); }
            .workflow-grid { grid-template-columns: repeat(2, 1fr); }
            .workflow-step::after { display: none; }
            .pricing-grid { grid-template-columns: 1fr; max-width: 380px; }
            .news-grid { grid-template-columns: repeat(2, 1fr); }
        }

        @media (max-width: 768px) {
            .nav-links { display: none; }
            .features-grid { grid-template-columns: 1fr; }
            .cta-form { flex-direction: column; }
            .footer-container { flex-direction: column; gap: 1.5rem; text-align: center; }
            .news-grid { grid-template-columns: 1fr; }
        }

        /* Animations */
        @keyframes fadeInUp {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .hero-eyebrow, .hero-title, .hero-subtitle, .hero-cta, .hero-questions {
            animation: fadeInUp 0.6s ease-out backwards;
        }

        .hero-eyebrow { animation-delay: 0s; }
        .hero-title { animation-delay: 0.1s; }
        .hero-subtitle { animation-delay: 0.2s; }
        .hero-cta { animation-delay: 0.3s; }
        .hero-questions { animation-delay: 0.4s; }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav>
        <div class="nav-container">
            <a href="/" class="logo">
                <span class="logo-text">Satya<span style="color: var(--accent-primary)">Bio</span></span>
            </a>
            <div class="nav-links">
                <a href="/targets">Targets</a>
                <a href="/companies">Companies</a>
                <a href="/kols">KOL Finder</a>
                <a href="/research">Research</a>
                <a href="/about">About</a>
            </div>
            <div style="display: flex; gap: 0.75rem;">
                <a href="#cta" class="btn btn-primary">Request Access</a>
            </div>
        </div>
    </nav>

    <!-- Hero -->
    <section class="hero">
        <div class="hero-container">
            <div class="hero-eyebrow">Biotech Competitive Intelligence</div>
            <h1 class="hero-title">
                Understand the <span class="highlight">landscape</span><br>
                before you invest
            </h1>
            <p class="hero-subtitle">
                Disease landscapes, competitive pipelines, clinical benchmarks, and KOL networks ‚Äî the research platform for biotech investors, VCs, and corporate BD.
            </p>
            <div class="hero-cta">
                <button class="btn btn-large btn-accent">Request Early Access</button>
                <button class="btn btn-large btn-ghost">See Demo ‚Üí</button>
            </div>

            <div class="hero-questions">
                <div class="question-card">
                    <div class="question-icon">üî¨</div>
                    <div class="question-text">What's the unmet need in nMIBC? What are patients getting today?</div>
                    <div class="question-answer">‚Üí Disease landscape</div>
                </div>
                <div class="question-card">
                    <div class="question-icon">‚öîÔ∏è</div>
                    <div class="question-text">Who else is targeting CD19 in lupus? What phase? What data?</div>
                    <div class="question-answer">‚Üí Competitive pipeline</div>
                </div>
                <div class="question-card">
                    <div class="question-icon">üìä</div>
                    <div class="question-text">What ORR did Keytruda show in 2L NSCLC? What's the AE profile?</div>
                    <div class="question-answer">‚Üí Clinical benchmarks</div>
                </div>
            </div>
        </div>
    </section>

    <!-- Disease Landscape Section -->
    <section class="landscape-section" id="landscape">
        <div class="section-container">
            <div class="section-header">
                <div class="section-eyebrow">Disease Landscapes</div>
                <h2 class="section-title">Start with the indication, not the company</h2>
                <p class="section-subtitle">
                    Understand what's approved, what's in development, and where the gaps are ‚Äî before you dive into any single asset.
                </p>
            </div>

            <div class="landscape-demo">
                <div class="landscape-sidebar">
                    <div class="sidebar-title">Therapeutic Areas</div>
                    <ul class="indication-list">
                        <li class="indication-item">
                            <span>Oncology</span>
                            <span class="indication-count">847</span>
                        </li>
                        <li class="indication-item active">
                            <span>Bladder Cancer</span>
                            <span class="indication-count">42</span>
                        </li>
                        <li class="indication-item" style="padding-left: 2rem;">
                            <span>nMIBC</span>
                            <span class="indication-count">12</span>
                        </li>
                        <li class="indication-item" style="padding-left: 2rem;">
                            <span>mUC</span>
                            <span class="indication-count">28</span>
                        </li>
                        <li class="indication-item">
                            <span>Immunology</span>
                            <span class="indication-count">312</span>
                        </li>
                        <li class="indication-item">
                            <span>Neurology</span>
                            <span class="indication-count">289</span>
                        </li>
                        <li class="indication-item">
                            <span>Metabolic</span>
                            <span class="indication-count">156</span>
                        </li>
                    </ul>
                </div>
                <div class="landscape-main">
                    <div class="landscape-header">
                        <div>
                            <div class="landscape-indication">nMIBC</div>
                            <div class="landscape-full-name">Non-Muscle Invasive Bladder Cancer (BCG-Unresponsive)</div>
                        </div>
                        <div class="landscape-stats">
                            <div class="landscape-stat">
                                <div class="landscape-stat-value green">2</div>
                                <div class="landscape-stat-label">Approved</div>
                            </div>
                            <div class="landscape-stat">
                                <div class="landscape-stat-value blue">8</div>
                                <div class="landscape-stat-label">Phase 2/3</div>
                            </div>
                            <div class="landscape-stat">
                                <div class="landscape-stat-value orange">~80K</div>
                                <div class="landscape-stat-label">US Patients/yr</div>
                            </div>
                        </div>
                    </div>

                    <div class="unmet-need">
                        <div class="unmet-need-title">
                            <span>‚ö†Ô∏è</span> Unmet Need
                        </div>
                        <div class="unmet-need-text">
                            BCG-unresponsive patients face radical cystectomy (bladder removal) as SOC. Only 2 drugs approved ‚Äî pembrolizumab (38% CR) and nadofaragene (24% CR). High unmet need for bladder-sparing options with durable responses.
                        </div>
                    </div>

                    <div class="soc-box">
                        <div class="soc-title">Current Standard of Care</div>
                        <div class="soc-drugs">
                            <div class="soc-drug">
                                <div class="soc-drug-info">
                                    <h4>Keytruda</h4>
                                    <span>Pembrolizumab ‚Ä¢ Merck</span>
                                </div>
                                <div class="soc-drug-sales">$25B/yr</div>
                            </div>
                            <div class="soc-drug">
                                <div class="soc-drug-info">
                                    <h4>Adstiladrin</h4>
                                    <span>Nadofaragene ‚Ä¢ Ferring</span>
                                </div>
                                <div class="soc-drug-sales">$180M/yr</div>
                            </div>
                        </div>
                    </div>

                    <div class="pipeline-section">
                        <div class="pipeline-title">Competitive Pipeline</div>
                        <table class="pipeline-table">
                            <thead>
                                <tr>
                                    <th>Company</th>
                                    <th>Drug</th>
                                    <th>Phase</th>
                                    <th>MOA</th>
                                    <th>Differentiation</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>
                                        <div class="company-cell">
                                            <span class="company-ticker">CGON</span>
                                            <span class="company-name">CG Oncology</span>
                                        </div>
                                    </td>
                                    <td class="drug-name">Cretostimogene</td>
                                    <td><span class="phase-badge phase-3">Phase 3</span></td>
                                    <td class="moa-text">Oncolytic virus (GM-CSF)</td>
                                    <td class="differentiation">75% CR in Ph2; intravesical</td>
                                </tr>
                                <tr>
                                    <td>
                                        <div class="company-cell">
                                            <span class="company-ticker">QURE</span>
                                            <span class="company-name">uniQure</span>
                                        </div>
                                    </td>
                                    <td class="drug-name">TAR-210</td>
                                    <td><span class="phase-badge phase-2">Phase 2</span></td>
                                    <td class="moa-text">Erdafitinib intravesical</td>
                                    <td class="differentiation">FGFR-targeted; local delivery</td>
                                </tr>
                                <tr>
                                    <td>
                                        <div class="company-cell">
                                            <span class="company-ticker">IOVA</span>
                                            <span class="company-name">Iovance</span>
                                        </div>
                                    </td>
                                    <td class="drug-name">IOV-4001</td>
                                    <td><span class="phase-badge phase-1">Phase 1</span></td>
                                    <td class="moa-text">TIL therapy</td>
                                    <td class="differentiation">Cell therapy approach</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Clinical Data Section -->
    <section class="clinical-section" id="clinical">
        <div class="section-container">
            <div class="clinical-grid">
                <div class="clinical-content">
                    <div class="section-eyebrow">Clinical Benchmarks</div>
                    <h3>Know what bar you need to clear</h3>
                    <p>
                        Before you get excited about Phase 2 data, understand what's already been shown. We normalize endpoints across trials so you can actually compare.
                    </p>
                    <p>
                        See ORR, CR rates, PFS, OS ‚Äî and the safety signals that matter. GI toxicity in oncology? Cytokine release in cell therapy? We track the AEs that move stocks.
                    </p>
                    <ul class="clinical-features">
                        <li>Efficacy endpoints normalized across trials (ORR, CR, PFS, OS)</li>
                        <li>Safety profiles with grade 3+ AE rates and discontinuation</li>
                        <li>Head-to-head comparisons where available</li>
                        <li>Historical approval benchmarks by indication</li>
                        <li>Conference data (ASCO, AACR, ASH, AAN) within 24 hours</li>
                    </ul>
                </div>
                <div class="efficacy-demo">
                    <div class="efficacy-header">
                        <span class="efficacy-title">Efficacy Comparison</span>
                        <span class="efficacy-indication">Ulcerative Colitis ‚Ä¢ Phase 3</span>
                    </div>
                    <div class="efficacy-body">
                        <table class="efficacy-table">
                            <thead>
                                <tr>
                                    <th>Drug</th>
                                    <th>Clinical Remission</th>
                                    <th>Endoscopic</th>
                                    <th>Key AEs</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td class="drug-cell">Obefazimod (ABVX)</td>
                                    <td><span class="efficacy-value high">45.2%</span></td>
                                    <td><span class="efficacy-value high">35.1%</span></td>
                                    <td class="safety-cell">
                                        <span class="ae-badge">Nasopharyngitis 8%</span>
                                    </td>
                                </tr>
                                <tr>
                                    <td class="drug-cell">Rinvoq (AbbVie)</td>
                                    <td><span class="efficacy-value high">42%</span></td>
                                    <td><span class="efficacy-value high">36%</span></td>
                                    <td class="safety-cell">
                                        <span class="ae-badge warning">Herpes zoster 4%</span>
                                    </td>
                                </tr>
                                <tr>
                                    <td class="drug-cell">Skyrizi (AbbVie)</td>
                                    <td><span class="efficacy-value medium">38%</span></td>
                                    <td><span class="efficacy-value medium">29%</span></td>
                                    <td class="safety-cell">
                                        <span class="ae-badge">URI 12%</span>
                                    </td>
                                </tr>
                                <tr>
                                    <td class="drug-cell">Entyvio (Takeda)</td>
                                    <td><span class="efficacy-value low">31%</span></td>
                                    <td><span class="efficacy-value low">26%</span></td>
                                    <td class="safety-cell">
                                        <span class="ae-badge">Headache 10%</span>
                                    </td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Features Section -->
    <section class="features-section" id="features">
        <div class="section-container">
            <div class="section-header">
                <div class="section-eyebrow">Platform</div>
                <h2 class="section-title">Everything you need, structured</h2>
            </div>
            <div class="features-grid">
                <div class="feature-card">
                    <div class="feature-icon">üó∫Ô∏è</div>
                    <div class="feature-title">Disease Landscapes</div>
                    <div class="feature-description">
                        Understand unmet need, SOC, and competitive dynamics for any indication. Start with the market, not the ticker.
                    </div>
                </div>
                <div class="feature-card">
                    <div class="feature-icon">‚öîÔ∏è</div>
                    <div class="feature-title">Competitive Pipelines</div>
                    <div class="feature-description">
                        See every drug targeting your indication ‚Äî phase, MOA, differentiators, and expected catalysts.
                    </div>
                </div>
                <div class="feature-card">
                    <div class="feature-icon">üìä</div>
                    <div class="feature-title">Clinical Benchmarks</div>
                    <div class="feature-description">
                        Efficacy and safety data normalized for comparison. Know what bar new entrants need to clear.
                    </div>
                </div>
                <div class="feature-card">
                    <div class="feature-icon">üë§</div>
                    <div class="feature-title">KOL Discovery</div>
                    <div class="feature-description">
                        Find the top researchers for any drug or indication. Publication history, institution, and email for outreach.
                    </div>
                </div>
                <div class="feature-card">
                    <div class="feature-icon">üìà</div>
                    <div class="feature-title">Smart Money Signals</div>
                    <div class="feature-description">
                        Track specialist fund positioning from 13F filings. See who's accumulating before data readouts.
                    </div>
                </div>
                <div class="feature-card">
                    <div class="feature-icon">üìë</div>
                    <div class="feature-title">Excel Exports</div>
                    <div class="feature-description">
                        Download comprehensive workbooks ‚Äî pipeline, comps, clinical data, KOLs ‚Äî formatted for IC presentations.
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Workflow Section -->
    <section class="workflow-section">
        <div class="section-container">
            <div class="section-header" style="text-align: center;">
                <div class="section-eyebrow">Workflow</div>
                <h2 class="section-title">From landscape to conviction</h2>
            </div>
            <div class="workflow-grid">
                <div class="workflow-step">
                    <div class="workflow-number">01</div>
                    <div class="workflow-title">Pick an Indication</div>
                    <div class="workflow-desc">Start with the disease. Understand unmet need, SOC, and market size.</div>
                </div>
                <div class="workflow-step">
                    <div class="workflow-number">02</div>
                    <div class="workflow-title">Map the Competition</div>
                    <div class="workflow-desc">See every drug in development. Phase, MOA, timeline, differentiation.</div>
                </div>
                <div class="workflow-step">
                    <div class="workflow-number">03</div>
                    <div class="workflow-title">Benchmark the Data</div>
                    <div class="workflow-desc">Compare efficacy and safety vs. SOC and competitors. Know the bar.</div>
                </div>
                <div class="workflow-step">
                    <div class="workflow-number">04</div>
                    <div class="workflow-title">Export & Present</div>
                    <div class="workflow-desc">Download Excel workbooks ready for IC. Call a KOL if you need more.</div>
                </div>
            </div>
        </div>
    </section>

    <!-- Hot Topics Section -->
    <section class="news-section" id="news">
        <div class="section-container">
            <div class="section-header">
                <div class="section-eyebrow">What's Moving</div>
                <h2 class="section-title">Hot topics the street is watching</h2>
                <p class="section-subtitle">
                    The stories and catalysts driving biotech sentiment right now.
                </p>
            </div>
            <div class="news-grid">
                <div class="news-card featured">
                    <div class="news-tag">PDUFA Watch</div>
                    <div class="news-ticker">INSM</div>
                    <h3 class="news-title">Brensocatib: First bronchiectasis drug ever?</h3>
                    <p class="news-summary">PDUFA Aug 12, 2025. First-in-class DPP1 inhibitor. Phase 3 ASPEN showed 21% reduction in exacerbations. $2B+ peak sales potential.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üéØ US Approval Decision</span>
                        <span class="news-sentiment positive">Specialist funds accumulating</span>
                    </div>
                </div>
                <div class="news-card">
                    <div class="news-tag">Gene Therapy</div>
                    <div class="news-ticker">RGNX</div>
                    <h3 class="news-title">Can RGX-202 beat Elevidys in DMD?</h3>
                    <p class="news-summary">Sarepta's Elevidys has boxed warning for liver deaths. RGNX's RGX-202 showing cleaner safety. Pivotal data Q2 2026.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üìä Pivotal Readout Q2 2026</span>
                        <span class="news-sentiment neutral">Street skeptical</span>
                    </div>
                </div>
                <div class="news-card">
                    <div class="news-tag">Rare Disease</div>
                    <div class="news-ticker">RGNX</div>
                    <h3 class="news-title">Hunter syndrome: First CNS gene therapy?</h3>
                    <p class="news-summary">RGX-121 PDUFA Feb 8, 2026. Would be first treatment to address neurological decline in MPS II. Priority Review Voucher at stake.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üéØ FDA Decision Feb 2026</span>
                        <span class="news-sentiment positive">PRV upside</span>
                    </div>
                </div>
                <div class="news-card">
                    <div class="news-tag">Obesity</div>
                    <div class="news-ticker">VKTX</div>
                    <h3 class="news-title">Viking's oral GLP-1: Enough differentiation?</h3>
                    <p class="news-summary">Phase 2 hit primary but discontinuation rates concerned investors. Oral convenience vs. Lilly/Novo injectables.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üìä Ph3 Design Coming</span>
                        <span class="news-sentiment negative">Stock down on data</span>
                    </div>
                </div>
                <div class="news-card">
                    <div class="news-tag">Autoimmune</div>
                    <div class="news-ticker">ABVX</div>
                    <h3 class="news-title">Obefazimod NDA filed for UC</h3>
                    <p class="news-summary">Novel oral MOA for ulcerative colitis. Phase 3 showed 45% remission. Competing with AbbVie's Rinvoq, but cleaner safety.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üéØ PDUFA Q2 2025</span>
                        <span class="news-sentiment positive">Baker Bros position</span>
                    </div>
                </div>
                <div class="news-card">
                    <div class="news-tag">Oncology</div>
                    <div class="news-ticker">CGON</div>
                    <h3 class="news-title">Cretostimogene: Bladder cancer breakthrough?</h3>
                    <p class="news-summary">Oncolytic virus for BCG-unresponsive nMIBC. 75% CR in Phase 2 vs. 38% for Keytruda. Pivotal data coming.</p>
                    <div class="news-meta">
                        <span class="news-catalyst">üìä Ph3 Data 2025</span>
                        <span class="news-sentiment positive">High conviction</span>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Pricing -->
    <section class="pricing-section" id="pricing">
        <div class="section-container">
            <div class="section-header" style="text-align: center;">
                <div class="section-eyebrow">Pricing</div>
                <h2 class="section-title">Simple pricing. No enterprise sales call.</h2>
            </div>
            <div class="pricing-grid">
                <div class="pricing-card">
                    <div class="pricing-name">Starter</div>
                    <div class="pricing-for">For individual investors</div>
                    <div class="pricing-price">$0</div>
                    <div class="pricing-period">Free forever</div>
                    <ul class="pricing-features">
                        <li>3 disease landscapes / month</li>
                        <li>Basic competitive pipeline view</li>
                        <li>Catalyst calendar</li>
                    </ul>
                    <button class="btn btn-ghost">Get Started</button>
                </div>
                <div class="pricing-card featured">
                    <div class="pricing-name">Pro</div>
                    <div class="pricing-for">For analysts & PMs</div>
                    <div class="pricing-price">$249<span>/mo</span></div>
                    <div class="pricing-period">Billed annually</div>
                    <ul class="pricing-features">
                        <li>Unlimited landscapes & companies</li>
                        <li>Clinical data comparisons</li>
                        <li>KOL discovery with emails</li>
                        <li>13F ownership tracking</li>
                        <li>Excel workbook exports</li>
                        <li>Priority support</li>
                    </ul>
                    <button class="btn btn-accent">Start 14-Day Trial</button>
                </div>
                <div class="pricing-card">
                    <div class="pricing-name">Team</div>
                    <div class="pricing-for">For funds & BD teams</div>
                    <div class="pricing-price">Custom</div>
                    <div class="pricing-period">Contact us</div>
                    <ul class="pricing-features">
                        <li>Everything in Pro</li>
                        <li>Unlimited seats</li>
                        <li>API access</li>
                        <li>Custom integrations</li>
                        <li>Dedicated support</li>
                    </ul>
                    <button class="btn btn-ghost">Contact Us</button>
                </div>
            </div>
        </div>
    </section>

    <!-- CTA -->
    <section class="cta-section">
        <div class="cta-container">
            <h2 class="cta-title">Ready to understand the landscape?</h2>
            <p class="cta-subtitle">
                Join the waitlist. We're onboarding biotech investors and BD teams every week.
            </p>
            <form class="cta-form">
                <input type="email" placeholder="work@fund.com">
                <button class="btn btn-accent" type="submit">Join Waitlist</button>
            </form>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="footer-container">
            <a href="/" class="logo">
                <span class="logo-text">Satya<span style="color: var(--accent-primary)">Bio</span></span>
            </a>
            <div class="footer-links">
                <a href="#">Privacy</a>
                <a href="#">Terms</a>
                <a href="#">Twitter</a>
                <a href="#">LinkedIn</a>
            </div>
            <div class="footer-copy">¬© 2025 SatyaBio</div>
        </div>
    </footer>

    <script>
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) target.scrollIntoView({ behavior: 'smooth', block: 'start' });
            });
        });

        window.addEventListener('scroll', () => {
            document.querySelector('nav').style.background =
                window.scrollY > 50 ? 'rgba(10, 10, 11, 0.95)' : 'rgba(10, 10, 11, 0.85)';
        });

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, { threshold: 0.1 });

        document.querySelectorAll('.feature-card, .workflow-step, .pricing-card').forEach(el => {
            el.style.opacity = '0';
            el.style.transform = 'translateY(20px)';
            el.style.transition = 'opacity 0.5s ease, transform 0.5s ease';
            observer.observe(el);
        });
    </script>
</body>
</html>
